TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Aurena Laboratories Holding AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
251,809
|
208,291
|
189,075 |
Financial expenses |
3,045
|
1,561
|
922 |
Earnings before taxes |
19,367
|
13,031
|
9,926 |
EBITDA |
29,721
|
19,557
|
16,078 |
Total assets |
218,878
|
186,709
|
166,883 |
Current assets |
87,888
|
85,942
|
69,097 |
Current liabilities |
45,274
|
50,432
|
31,363 |
Equity capital |
118,692
|
98,471
|
92,859 |
- share capital |
507
|
473
|
488 |
Employees (average) |
79
|
76
![]() |
76 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
54.2%
|
52.7%
|
55.6% |
Turnover per employee |
3,187
|
2,741
|
2,488 |
Profit as a percentage of turnover |
7.7%
|
6.3%
|
5.2% |
Return on assets (ROA) |
10.2%
|
7.8%
|
6.5% |
Current ratio |
194.1%
|
170.4%
|
220.3% |
Return on equity (ROE) |
16.3%
|
13.2%
|
10.7% |
Change turnover |
28,739
|
24,898
|
27,650 |
Change turnover % |
13%
|
14%
|
17% |
Chg. No. of employees |
3
|
0
|
2 |
Chg. No. of employees % |
4%
|
0%
|
3% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.